Marc A. Brouwer

ORCID: 0000-0001-8617-7672
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Arrest and Resuscitation
  • Acute Myocardial Infarction Research
  • Atrial Fibrillation Management and Outcomes
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Cardiac electrophysiology and arrhythmias
  • Coronary Interventions and Diagnostics
  • Cardiac Imaging and Diagnostics
  • Cardiac Arrhythmias and Treatments
  • Trauma and Emergency Care Studies
  • Cardiomyopathy and Myosin Studies
  • Cardiovascular Function and Risk Factors
  • Cardiac pacing and defibrillation studies
  • Venous Thromboembolism Diagnosis and Management
  • Cardiovascular Effects of Exercise
  • ECG Monitoring and Analysis
  • Non-Invasive Vital Sign Monitoring
  • Heart Rate Variability and Autonomic Control
  • Emergency and Acute Care Studies
  • Trauma Management and Diagnosis
  • Health Systems, Economic Evaluations, Quality of Life
  • Mechanical Circulatory Support Devices
  • Healthcare Technology and Patient Monitoring
  • Disaster Response and Management
  • Lipoproteins and Cardiovascular Health
  • Traumatic Brain Injury Research

Radboud University Nijmegen
2015-2025

Radboud University Medical Center
2015-2025

University Medical Center
2016-2025

Erasmus MC
2024

Amsterdam University Medical Centers
2024

University of Amsterdam
1995-2024

Radboud Institute for Molecular Life Sciences
2019

Institute of Cardiology
2019

Technische Universität Dresden
2007

Netherlands Heart Institute
2002

Catheter ablation of atrial fibrillation is typically performed with uninterrupted anticoagulation warfarin or interrupted non-vitamin K antagonist oral anticoagulant therapy. Uninterrupted a anticoagulant, such as dabigatran, may be safer; however, controlled data are lacking. We investigated the safety dabigatran versus in patients undergoing fibrillation.In this randomized, open-label, multicenter, trial blinded adjudicated end-point assessments, we randomly assigned scheduled for...

10.1056/nejmoa1701005 article EN New England Journal of Medicine 2017-03-19

The subcutaneous implantable cardioverter-defibrillator (ICD) was designed to avoid complications related the transvenous ICD lead by using an entirely extrathoracic placement. Evidence comparing these systems has been based primarily on observational studies.We conducted a noninferiority trial in which patients with indication for but no pacing were assigned receive or ICD. primary end point composite of device-related and inappropriate shocks; margin upper boundary 95% confidence interval...

10.1056/nejmoa1915932 article EN New England Journal of Medicine 2020-08-05

<b>Objective</b>&nbsp;To determine whether the treatment effect of apixaban versus warfarin differs with increasing numbers concomitant drugs used by patients atrial fibrillation. <b>Design</b>&nbsp;Post hoc analysis performed in 2015 results from ARISTOTLE (apixaban for reduction stroke and other thromboembolic events fibrillation)—a multicentre, double blind, dummy trial that started 2006 ended 2011. <b>Participants</b>&nbsp;18 201 participants. <b>Interventions</b>&nbsp;In trial, were...

10.1136/bmj.i2868 article EN cc-by-nc BMJ 2016-06-15

Bystander cardiopulmonary resuscitation (CPR) is crucial for survival after cardiac arrest but not performed in most cases. New, low-cost, and easily accessible training methods, such as virtual reality (VR), may reach broader target populations, data on achieved CPR skills are lacking.To compare quality between VR face-to-face training.Randomized noninferiority trial with a prospective randomized open blinded end point design. Participants were adult attendees from the science section of...

10.1001/jamacardio.2019.4992 article EN JAMA Cardiology 2019-11-17

The subcutaneous implantable cardioverter-defibrillator (S-ICD) is developed to overcome lead-related complications and systemic infections, inherent transvenous ICD (TV-ICD) therapy. PRAETORIAN trial demonstrated that the S-ICD non-inferior TV-ICD with regard combined primary endpoint of inappropriate shocks complications. This prespecified secondary analysis evaluates all in trial.The an international, multicentre, randomized which 849 patients indication for therapy were receive S- (N =...

10.1093/eurheartj/ehac496 article EN cc-by-nc European Heart Journal 2022-08-28

Unwitnessed out-of-hospital cardiac arrest is associated with low survival chances because of the delayed activation emergency medical system in most cases. Automated detection and alarming using biosensor technology would offer a potential solution to provide early help. We developed validated an algorithm for automated circulatory wrist-derived photoplethysmography from patients induced arrests.

10.1016/s2589-7500(23)00249-2 article EN cc-by The Lancet Digital Health 2024-02-21

Background — Despite the use of aspirin, reocclusion infarct-related artery occurs in ≈30% patients within first year after successful fibrinolysis, with impaired clinical outcome. This study sought to assess impact a prolonged anticoagulation regimen as adjunctive aspirin prevention and recurrent ischemic events fibrinolysis for ST-elevation myocardial infarction. Methods Results At coronary angiography &lt;48 hours fibrinolytic therapy, 308 receiving intravenous heparin had patent...

10.1161/01.cir.0000024408.81821.32 article EN Circulation 2002-08-06

BACKGROUND: Approximately 15% of saphenous vein grafts (SVGs) occlude during the first year after coronary artery bypass graft surgery (CABG) despite aspirin use. The POPular CABG trial (The Effect Ticagrelor on Saphenous Vein Graft Patency in Patients Undergoing Coronary Artery Bypass Grafting Surgery) investigated whether ticagrelor added to standard improves SVG patency at 1 CABG. METHODS: In this investigator-initiated, randomized, double-blind, placebo-controlled, multicenter trial,...

10.1161/circulationaha.120.050749 article EN Circulation 2020-08-31
Reinoud E. Knops Willeke van der Stuijt Peter Paul H.M. Delnoy Lucas V.A. Boersma Juergen Kuschyk and 93 more Mikhael F. El‐Chami Hendrik Bonnemeier Elijah R. Behr Tom F. Brouwer Stefan Kääb Suneet Mittal Anne‐Floor B.E. Quast Lonneke Smeding Jan G.P. Tijssen Nick R. Bijsterveld Sergio Richter Marc A. Brouwer Joris R. de Groot Kirsten M. Kooiman Pier D. Lambiase Petr Neužil Kevin Vernooy Marco Alings Timothy R. Betts Frank Bracke Martin C. Burke Jonas S.S.G. de Jong David J. Wright Ward P.J. Jansen Zachary I. Whinnet Peter Nordbeck Michael Knaut Berit T. Philbert Jurren M. van Opstal Alexandru B. Chicos Cornelis P. Allaart Alida E. Borger van der Burg Jude Clancy José Dizon Marc A. Miller Dmitry Nemirovsky Ralf Surber Gaurav A. Upadhyay Raul Weiss Anouk de Weger Arthur A.M. Wilde Louise R.A. Olde Nordkamp Marco Alings Cornelis P. Allaart Elijah R. Behr Timothy R. Betts Nick R. Bijsterveld Lucas V.A. Boersma Hendrik Bonnemeier Alida E. Borger van der Burg Frank Bracke Marc A. Brouwer Tom F. Brouwer Martin C. Burke Jim W. Cheung Alexandru B. Chicos Jude Clancy Peter Paul H.M. Delnoy José Dizon Mikhael F. El‐Chami Tjeerd Germans Joris R. de Groot Ward P.J. Jansen Jonas S.S.G. de Jong Stefan Kääb Michael Knaut Reinoud E. Knops Kirsten M. Kooiman Juergen Kuschyk Pier D. Lambiase Francisco Leyva Marc A. Miller Suneet Mittal Dmitry Nemirovsky Petr Neužil Peter Nordbeck Louise R.A. Olde Nordkamp Jurren M. van Opstal Berit T. Philbert Anne‐Floor B.E. Quast Sergio Richter Lonneke Smeding Willeke van der Stuijt Ralf Surber Dominic A.M.J. Theuns Jan G.P. Tijssen Gaurav A. Upadhyay Kevin Vernooy Anouk de Weger Raul Weiss Zachary I. Whinnet Arthur A.M. Wilde David J. Wright

The PRAETORIAN trial (A Prospective, Randomized Comparison of Subcutaneous and Transvenous Implantable Cardioverter Defibrillator Therapy) showed noninferiority subcutaneous implantable cardioverter defibrillator (S-ICD) compared with transvenous (TV-ICD) regard to inappropriate shocks complications. In contrast TV-ICD, S-ICD cannot provide antitachycardia pacing for monomorphic ventricular tachycardia. This prespecified secondary analysis evaluates appropriate therapy whether reduces the...

10.1161/circulationaha.121.057816 article EN cc-by-nc-nd Circulation 2021-11-14

<h3>Importance</h3> Increased bystander cardiopulmonary resuscitation (CPR) is essential to improve survival after cardiac arrest. Although most studies focus on technical CPR skills, the randomized Lowlands Saves Lives trial prespecified a follow-up survey other important aspects that affect widespread performance of CPR. <h3>Objective</h3> To investigate willingness perform stranger, theoretical knowledge retention, and dissemination awareness 6 months undergoing short face-to-face virtual...

10.1001/jamanetworkopen.2022.12964 article EN cc-by-nc-nd JAMA Network Open 2022-05-19

Parkinson's disease (PD) is a neurodegenerative disorder with wide range of motor and non-motor symptoms. Despite optimal medical management, PD still results in high disability rate secondary complications many patients lead sedentary lifestyle, which turn also associated higher co-morbidity mortality. Exercise has been explored as strategy to reduce suggests that it not only provides general health benefits, but may provide symptomatic relief. If this holds true exercise would be very...

10.1186/s12883-015-0312-6 article EN cc-by BMC Neurology 2015-04-15

Abstract Aims This study was performed to develop and externally validate prediction models for appropriate implantable cardioverter-defibrillator (ICD) shock mortality identify subgroups with insufficient benefit from ICD implantation. Methods results We recruited patients scheduled primary prevention implantation reduced left ventricular function. Bootstrapping-based Cox proportional hazards Fine Gray competing risk likely candidate predictors were developed all-cause shock, respectively....

10.1093/europace/euab012 article EN cc-by-nc EP Europace 2021-01-08
Coming Soon ...